
Iran and its Lebanese Hezbollah militia proxy on Thursday fired rockets again at Israel, where people are currently celebrating Passover.
In the morning, warning sirens sounded repeatedly in northern Israel. Two men were slightly injured by a Hezbollah rocket, the Magen David Adom emergency service said.
An Iranian rocket also aimed at the north was fitted with cluster munitions, Israeli media reported. The use of cluster munitions is widely banned internationally because they can scatter explosive devices uncontrollably over large areas and are particularly dangerous for civilians.
There was also repeated fire at Israel overnight. A rocket alert was triggered in the coastal metropolis of Tel Aviv, among other places. Magen David Adom reported several people with minor injuries from broken glass in a suburb of Tel Aviv, including two babies.
The week-long Passover festival began on Wednesday evening for Jews around the world. It commemorates the exodus of the Israelites from Egypt and their liberation from slavery.
latest_posts
- 1
Benihana is 60 years old. Gen Z is lining up. - 2
Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps - 3
Hezbollah uses ambulances, paramedic uniforms, as disguise for terrorist activity, IDF says - 4
Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump - 5
KJ Apa stars as Jimmy Stewart in new biopic: See his transformation
Bullets in Luigi Mangione’s bag convinced police that he was UnitedHealthcare CEO killing suspect
Empathy and reasoning aren’t rivals – new research shows they work together to drive people to help more
Strength training is crucial after menopause. How to make the most of your workouts
Going with Children: Tips for Tranquil Family Get-aways
This Overlooked Predator Is Running Out of Time—Why Conservationists Are Racing to Save the Striped Hyena
UAE-backed Yemeni Southern Transitional Council denies disbandment rumors
Family-Accommodating Snow Sports Experiences
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
The Most Compelling Innovation Advancements Somewhat recently












